HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Biomarker Value of miR-221 and miR-222 as Potential Substrates in the Differential Diagnosis of Papillary Thyroid Cancer Based on Data Synthesis and Bioinformatics Approach.

AbstractBackground:
MicroRNA (miRNA) has been reported to play a critical regulatory role in papillary thyroid carcinomas (PTC). However, the role of miR-221/222 in PTC remains unclear. Here, we performed this study to explore the diagnostic potentials and mechanisms of miR-221/222 in PTC.
Methods:
First, we systematically analyzed the diagnostic value of miR-221/222 in the diagnosis PTC by pooling the published studies. Afterwards, we performed comprehensive bioinformatics analysis including gene ontology analysis, pathway enrichment analysis and protein-protein interaction analysis to explore the potential mechanisms of miR-221/222 involved in PTC.
Results:
The overall sensitivity and specificity of miR-221/222 for PTC were 0.75 (95% CI: 0.70-0.80) and 0.80 (95% CI: 0.76-0.84) respectively with the AUC of 0.85 (95% CI: 0.81-0.88). The diagnostic performance varied among different subgroups including geographical locations, sample sources and sample sizes. Meanwhile, we found that a combination of miR-221/222 and other miRNAs when used in a diagnostic panel could improve the diagnostic accuracy than individual miR-221/222. Moreover, through the bioinformatics analysis, we confirmed that miR-221/222 targets were highly related to the molecular pathogenesis of PTC. The results revealed that miR-221/222 may exert important functions in PTC through thyroid hormone signaling pathway and some other key pathways by regulating some key genes.
Conclusion:
These findings indicated that miR-221/222 have the potential to serve as auxiliary tools for diagnosing PTC. Further prospective clinical trials should be performed to assess the accuracy of these findings in a larger cohort and determine the clinical uses.
AuthorsShang Cai, Jiayan Ma, Yong Wang, Yuxing Cai, Liwei Xie, Xiangying Chen, Yingying Yang, Qiliang Peng
JournalFrontiers in endocrinology (Front Endocrinol (Lausanne)) Vol. 12 Pg. 794490 ( 2021) ISSN: 1664-2392 [Print] Switzerland
PMID35197926 (Publication Type: Research Support, Non-U.S. Gov't, Systematic Review)
CopyrightCopyright © 2022 Cai, Ma, Wang, Cai, Xie, Chen, Yang and Peng.
Chemical References
  • Biomarkers
  • MIRN221 microRNA, human
  • MIRN222 microRNA, human
  • MicroRNAs
Topics
  • Biomarkers
  • Computational Biology
  • Diagnosis, Differential
  • Humans
  • MicroRNAs (genetics, metabolism)
  • Thyroid Cancer, Papillary (diagnosis, genetics, pathology)
  • Thyroid Neoplasms (diagnosis, genetics, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: